{
    "clinical_study": {
        "@rank": "144667", 
        "arm_group": [
            {
                "arm_group_label": "Lisdexamfetamine Dimesylate Fasting", 
                "arm_group_type": "Experimental", 
                "description": "lisdexamfetamine dimesylate 70 mg capsule administered under fasted conditions"
            }, 
            {
                "arm_group_label": "Lisdexamfetamine Dimesylate Vanilla Yogurt", 
                "arm_group_type": "Experimental", 
                "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt"
            }, 
            {
                "arm_group_label": "Lisdexamfetamine Dimesylate Orange Juice", 
                "arm_group_type": "Experimental", 
                "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice"
            }
        ], 
        "brief_summary": {
            "textblock": "Compare the pharmacokinetic profiles when the contents are emptied into a soft food and\n      orange juice compared to the SPD489 when swallowed as an intact capsule."
        }, 
        "brief_title": "Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for first intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for second intervention; then Lisdexamfetamine Dimesylate 70mg intact capsule fasting for third intervention", 
                            "title": "Sequence 1"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for first intervention; then Lisdexamfetamine Dimesylate 70mg intact capsule fasting for second intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for third intervention", 
                            "title": "Sequence 2"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for first intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for second intervention; then Lisdexamfetamine Dimesylate 70mg intact capsule fasting for third intervention", 
                            "title": "Sequence 3"
                        }, 
                        {
                            "@group_id": "B4", 
                            "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for first intervention; then Lisdexamfetamine Dimesylate 70mg intact capsule fasting for second intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for third intervention", 
                            "title": "Sequence 4"
                        }, 
                        {
                            "@group_id": "B5", 
                            "description": "Lisdexamfetamine Dimesylate 70mg intact capsule fasting for first intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for second intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for third intervention", 
                            "title": "Sequence 5"
                        }, 
                        {
                            "@group_id": "B6", 
                            "description": "Lisdexamfetamine Dimesylate 70mg intact capsule fasting for first intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for second intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for third intervention", 
                            "title": "Sequence 6"
                        }, 
                        {
                            "@group_id": "B7", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B6", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B7", 
                                                "@value": "30"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "10.16", 
                                                "@value": "32.6"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "12.42", 
                                                "@value": "35.4"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "4.44", 
                                                "@value": "42.2"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@spread": "12.42", 
                                                "@value": "34.2"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@spread": "9.86", 
                                                "@value": "39.6"
                                            }, 
                                            {
                                                "@group_id": "B6", 
                                                "@spread": "10.06", 
                                                "@value": "41.8"
                                            }, 
                                            {
                                                "@group_id": "B7", 
                                                "@spread": "10.07", 
                                                "@value": "37.6"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "Years"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B6", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B7", 
                                                "@value": "30"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "Between 18 and 65 years, inclusive"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Age, Customized", 
                            "units": "Participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B6", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B7", 
                                                    "@value": "8"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "3"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "5"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "3"
                                                }, 
                                                {
                                                    "@group_id": "B6", 
                                                    "@value": "3"
                                                }, 
                                                {
                                                    "@group_id": "B7", 
                                                    "@value": "22"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "Participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B6", 
                                                "@value": "5"
                                            }, 
                                            {
                                                "@group_id": "B7", 
                                                "@value": "30"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "UNITED STATES"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "Participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "0.655", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "0.766", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of geometric least squares means", 
                                    "param_value": "0.708"
                                }, 
                                {
                                    "ci_lower_limit": "0.849", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "0.992", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of geometric least squares means", 
                                    "param_value": "0.918"
                                }
                            ]
                        }, 
                        "description": "AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Mixed in Orange Juice"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Mixed in Vanilla Yogurt"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Lisdexamfetamine Dimesylate 70 mg capsule administered under fasted conditions (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Intact Capsule Fasting"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "30"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "30"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "30"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "7.8", 
                                                        "@value": "27.0"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "14.2", 
                                                        "@value": "36.0"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "12.3", 
                                                        "@value": "38.3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Area Under the Plasma Concentration-time Curve (AUC) for Lisdexamfetamine Dimesylate", 
                                    "units": "ng*hr/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic Set consisted of all subjects in the Safety Set for whom the primary pharmacokinetic data were considered sufficient and interpretable. Safety Set consisted of subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Up to 96 hours post-dose", 
                        "title": "Area Under the Plasma Concentration-time Curve (AUC) for Lisdexamfetamine Dimesylate", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "0.582", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "0.707", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of geometric least squares means", 
                                    "param_value": "0.641"
                                }, 
                                {
                                    "ci_lower_limit": "0.752", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "0.912", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of geometric least squares means", 
                                    "param_value": "0.828"
                                }
                            ]
                        }, 
                        "description": "Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administrated.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Mixed in Orange Juice"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Mixed in Vanilla Yogurt"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "lisdexamfetamine dimesylate 70 mg capsule administered under fasted conditions (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Intact Capsule Fasting"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "30"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "30"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "30"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "7.48", 
                                                        "@value": "24.5"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "11.46", 
                                                        "@value": "32.2"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "13.07", 
                                                        "@value": "38.5"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administrated.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Maximum Plasma Concentration (Cmax) for Lisdexamfetamine Dimesylate", 
                                    "units": "ng/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic Set consisted of all subjects in the Safety Set for whom the primary pharmacokinetic data were considered sufficient and interpretable. Safety Set consisted of subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Up to 96 hours post-dose", 
                        "title": "Maximum Plasma Concentration (Cmax) for Lisdexamfetamine Dimesylate", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "0.937", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "1.004", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of geometric least squares means", 
                                    "param_value": "0.970"
                                }, 
                                {
                                    "ci_lower_limit": "0.912", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "0.977", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of geometric least squares means", 
                                    "param_value": "0.944"
                                }
                            ]
                        }, 
                        "description": "d-Amphetamine is a metabolite of Lisdexamfetamine Dimesylate and is an active form that is responsible for the drug's therapeutic activity.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Mixed in Orange Juice"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Mixed in Vanilla Yogurt"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "lisdexamfetamine dimesylate 70 mg capsule administered under fasted conditions (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Intact Capsule Fasting"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "30"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "30"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "30"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "274.1", 
                                                        "@value": "1140.9"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "252.9", 
                                                        "@value": "1110.1"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "295.1", 
                                                        "@value": "1180.2"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "d-Amphetamine is a metabolite of Lisdexamfetamine Dimesylate and is an active form that is responsible for the drug's therapeutic activity.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "AUC for D-amphetamine", 
                                    "units": "ng*h/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic Set consisted of all subjects in the Safety Set for whom the primary pharmacokinetic data were considered sufficient and interpretable. Safety Set consisted of subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Up to 96 hours post-dose", 
                        "title": "AUC for D-amphetamine", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "0.945", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "0.998", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of geometric least squares means", 
                                    "param_value": "0.971"
                                }, 
                                {
                                    "ci_lower_limit": "0.944", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "0.997", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of geometric least squares means", 
                                    "param_value": "0.970"
                                }
                            ]
                        }, 
                        "description": "d-Amphetamine is a metabolite of Lisdexamfetamine Dimesylate and is an active form that is responsible for the drug's therapeutic activity.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Mixed in Orange Juice"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Mixed in Vanilla Yogurt"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "lisdexamfetamine dimesylate 70 mg capsule administered under fasted conditions (Single dose of a 70 mg capsule on Day 1)", 
                                    "title": "Lisdexamfetamine Dimesylate Intact Capsule Fasting"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "30"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "30"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "30"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "9.47", 
                                                        "@value": "59.1"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "9.28", 
                                                        "@value": "59.0"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "10.81", 
                                                        "@value": "61.0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "d-Amphetamine is a metabolite of Lisdexamfetamine Dimesylate and is an active form that is responsible for the drug's therapeutic activity.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Cmax for D-amphetamine", 
                                    "units": "ng/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic Set consisted of all subjects in the Safety Set for whom the primary pharmacokinetic data were considered sufficient and interpretable. Safety Set consisted of subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Up to 96 hours-post-dose", 
                        "title": "Cmax for D-amphetamine", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for first intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for second intervention; then Lisdexamfetamine Dimesylate 70mg intact capsule fasting for third intervention", 
                            "title": "Sequence 1"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for first intervention; then Lisdexamfetamine Dimesylate 70mg intact capsule fasting for second intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for third intervention", 
                            "title": "Sequence 2"
                        }, 
                        {
                            "@group_id": "P3", 
                            "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for first intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for second intervention; then Lisdexamfetamine Dimesylate 70mg intact capsule fasting for third intervention", 
                            "title": "Sequence 3"
                        }, 
                        {
                            "@group_id": "P4", 
                            "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for first intervention; then Lisdexamfetamine Dimesylate 70mg intact capsule fasting for second intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for third intervention", 
                            "title": "Sequence 4"
                        }, 
                        {
                            "@group_id": "P5", 
                            "description": "Lisdexamfetamine Dimesylate 70mg intact capsule fasting for first intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for second intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for third intervention", 
                            "title": "Sequence 5"
                        }, 
                        {
                            "@group_id": "P6", 
                            "description": "Lisdexamfetamine Dimesylate 70mg intact capsule fasting for first intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt for second intervention; then Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice for third intervention", 
                            "title": "Sequence 6"
                        }
                    ]
                }, 
                "period_list": {
                    "period": [
                        {
                            "milestone_list": {
                                "milestone": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P4"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P5"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P6"
                                                }
                                            ]
                                        }, 
                                        "title": "STARTED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P4"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P5"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P6"
                                                }
                                            ]
                                        }, 
                                        "title": "COMPLETED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P4"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P5"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P6"
                                                }
                                            ]
                                        }, 
                                        "title": "NOT COMPLETED"
                                    }
                                ]
                            }, 
                            "title": "First Intervention"
                        }, 
                        {
                            "milestone_list": {
                                "milestone": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P4"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P5"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P6"
                                                }
                                            ]
                                        }, 
                                        "title": "STARTED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P4"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P5"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P6"
                                                }
                                            ]
                                        }, 
                                        "title": "COMPLETED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P4"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P5"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P6"
                                                }
                                            ]
                                        }, 
                                        "title": "NOT COMPLETED"
                                    }
                                ]
                            }, 
                            "title": "Second Intervention"
                        }, 
                        {
                            "drop_withdraw_reason_list": {
                                "drop_withdraw_reason": {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P4"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P5"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P6"
                                            }
                                        ]
                                    }, 
                                    "title": "Withdrawal by Subject"
                                }
                            }, 
                            "milestone_list": {
                                "milestone": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P4"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P5"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P6"
                                                }
                                            ]
                                        }, 
                                        "title": "STARTED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "4", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P4"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P5"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P6"
                                                }
                                            ]
                                        }, 
                                        "title": "COMPLETED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P4"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P5"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P6"
                                                }
                                            ]
                                        }, 
                                        "title": "NOT COMPLETED"
                                    }
                                ]
                            }, 
                            "title": "Third Intervention"
                        }
                    ]
                }
            }, 
            "point_of_contact": {
                "name_or_title": "Study Physician", 
                "organization": "Shire Development LLC", 
                "phone": "+1 866 842 5335"
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into orange juice (Single dose of a 70 mg capsule on Day 1)", 
                            "title": "Lisdexamfetamine Dimesylate Mixed in Orange Juice"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Lisdexamfetamine Dimesylate 70mg capsule mixed into vanilla yogurt(Single dose of a 70 mg capsule on Day 1)", 
                            "title": "Lisdexamfetamine Dimesylate Mixed in Vanilla Yogurt"
                        }, 
                        {
                            "@group_id": "E3", 
                            "description": "Lisdexamfetamine Dimesylate 70 mg capsule administered under fasted conditions (Single dose of a 70 mg capsule on Day 1)", 
                            "title": "Lisdexamfetamine Dimesylate Intact Capsule Fasting"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "16", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "17", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "9", 
                                                "@subjects_at_risk": "30"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "3", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            {
                                                "@events": "5", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            {
                                                "@events": "3", 
                                                "@group_id": "E3", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "30"
                                            }
                                        ], 
                                        "sub_title": "Dry mouth"
                                    }
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "9", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "9", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            {
                                                "@events": "8", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "8", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            {
                                                "@events": "3", 
                                                "@group_id": "E3", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "30"
                                            }
                                        ], 
                                        "sub_title": "Decreased appetite"
                                    }
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "30"
                                                }, 
                                                {
                                                    "@events": "2", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "30"
                                                }, 
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "30"
                                                }
                                            ], 
                                            "sub_title": "Dizziness"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@events": "4", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "30"
                                                }, 
                                                {
                                                    "@events": "3", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "30"
                                                }, 
                                                {
                                                    "@events": "4", 
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "30"
                                                }
                                            ], 
                                            "sub_title": "Headache"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "30"
                                                }, 
                                                {
                                                    "@events": "2", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "30"
                                                }, 
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "30"
                                                }
                                            ], 
                                            "sub_title": "Psychomotor hyperactivity"
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            {
                                                "@events": "2", 
                                                "@group_id": "E3", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "30"
                                            }
                                        ], 
                                        "sub_title": "Anxiety"
                                    }
                                }, 
                                "title": "Psychiatric disorders"
                            }
                        ]
                    }, 
                    "frequency_threshold": "5"
                }
            }
        }, 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age 18-55 years inclusive at the time of consent. The date of signing informed\n             consent is defined as the beginning of the Screening Period. This inclusion criterion\n             will only be assessed at the first screening visit.\n\n          2. Willingness to comply with any applicable contraceptive requirements fo the protocol\n             and is:\n\n               -  Male, or\n\n               -  Non pregnant, non lactating female\n\n               -  Females must be at least 90 days post partum or nulliparous\n\n          3. Must be considered \"healthy\". Healthy status is defined by absence of evidence of any\n             active or chronic disease following a detailed medical and surgical history, a\n             complete physical examination including vital signs, 12-lead electrocardiogram,\n             hematology, blood chemistry, and urinalysis.\n\n          4. An understanding, ability, and willingness to fully comply with study procedures and\n             restrictions\n\n          5. Ability to provide written, personally signed, and dated informed consent to\n             participate in the study, in accordance with International Conference on\n             harmonisation Good Clinical Practice Guideline E6 (1996) and applicable regulations,\n             before completing any study related procedures\n\n          6. A body mass index between 18.5-30.0kg/m\u00b2 inclusive.  This inclusion criterion will\n             only be assessed at the first screening visit.\n\n          7. A hemoglobin value of >=12.0g/dL at the Screening Visit and on Day -1 of Treatment\n             Period 1.\n\n          8. Ability to swallow a dose of investigational product according to the study\n             conditions.\n\n        Exclusion Criteria:\n\n        Subjects are excluded from the study if any of the following criteria are met at the\n        Screening Visit or at Day  1 of Treatment Period 1 (if reassessed):\n\n          1. Current or recurrent disease (eg, cardiovascular, renal, liver, gastrointestinal,\n             malignancy, or other conditions) that could affect the action, absorption, or\n             disposition of the investigational products, or could affect clinical or laboratory\n             assessments.\n\n          2. Current or relevant history of physical or psychiatric illness, any medical disorder\n             that may require treatment or make the subject unlikely to fully comply with the\n             requirements of the study or complete the study, or any condition that presents undue\n             risk from the investigational product or study procedures.\n\n          3. Significant illness, as judged by the investigator, within 2 weeks of the first dose\n             of investigational product.\n\n          4. History of significant anxiety, tension, or agitation as assessed by the\n             investigator.\n\n          5. History of or current diagnosis of glaucoma.\n\n          6. History of a seizure disorder (other than infantile febrile seizures), any tic\n             disorder, or a current diagnosis and/or known family history of Tourette's Disorder.\n\n          7. History or presence of known structural cardiac abnormalities, syncope, cardiac\n             conduction problems, exercise-related cardiac events, or clinically significant\n             bradycardia.\n\n          8. History of symptomatic cardiovascular disease, advanced arteriosclerosis, structural\n             cardiac abnormality, cardiomyopathy, serious heart rhythm abnormalities, coronary\n             artery disease, transient ischemic attack or stroke or other serious cardiac problems\n             that may place them at increased vulnerability to the sympathomimetic effects of a\n             stimulant drug.\n\n          9. History of controlled or uncontrolled hypertension or a resting supine systolic blood\n             pressure >139mmHg or diastolic blood pressure >89mmHg.\n\n         10. Known family history of sudden cardiac death or ventricular arrhythmia.\n\n         11. Currently considered a suicide risk, has previously made a suicide attempt, or has a\n             history of, or is currently demonstrating suicidal ideation.\n\n         12. Current use of any medication (including prescription, over-the-counter, herbal or\n             homeopathic preparations) with the exception of hormonal replacement therapy or\n             hormonal contraceptives (current use is defined as use within 14 days of first dose\n             of investigational product).\n\n         13. Use of any medication known to inhibit or induce the cytochrome P450 (CYP450) enzymes\n             responsible for the metabolism of the investigational product within 14 days of first\n             dose of investigational product.\n\n         14. Known or suspected intolerance or hypersensitivity to the investigational product,\n             closely related compounds, or any of the stated ingredients.\n\n         15. Known or suspected intolerance or hypersensitivity to orange juice or vanilla yogurt.\n\n         16. History of alcohol or other substance abuse within the last year.\n\n         17. A positive screen for alcohol or drugs of abuse at the Screening Visit or on Day  1\n             of Treatment Period 1.\n\n         18. Male subjects who consume more than 3 units of alcohol per day.  Female subjects who\n             consume more than 2 units of alcohol per day.  (1 alcohol unit=1 beer=1 wine\n             [5oz]=one liquor [1.5 oz]=0.75oz alcohol.).\n\n         19. A positive human immunodeficiency virus antibody screen, Hepatitis B surface antigen,\n             or Hepatitis C virus antibody screen.\n\n         20. Use of tobacco in any form (eg, smoking or chewing) or other nicotine-containing\n             products in any form (eg, gum, patch) within 30 days prior to the first dose of\n             investigational product.\n\n         21. Routine consumption of more than 2 units of caffeine per day or subjects who\n             experience caffeine withdrawal headaches or have a history of caffeine withdrawal\n             headaches.  (One caffeine unit is contained in the following items:  one 6oz cup of\n             coffee, two 12oz cans of cola, one 12oz cup of tea, three 1oz chocolate bars.\n             Decaffeinated coffee, tea, or cola are not considered to contain caffeine).\n\n         22. Donation of blood or blood products (eg, plasma or platelets) within 60 days prior to\n             the first dose of investigational product.\n\n         23. Use of another investigational product within 30 days prior to receiving the first\n             dose of investigational product or active enrollment in another drug or vaccine\n             clinical study.\n\n         24. Substantial changes in eating habits within 30 days prior to receiving the first dose\n             of investigational product, as assessed by the investigator.\n\n         25. An inability to follow a standardized diet and meal schedule or inability to fast, as\n             required during the study.\n\n         26. Prior screen failure, randomization, participation, or enrollment in this study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 27, 2013", 
        "firstreceived_results_date": "March 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01890785", 
            "org_study_id": "SPD489-123"
        }, 
        "intervention": {
            "arm_group_label": [
                "Lisdexamfetamine Dimesylate Fasting", 
                "Lisdexamfetamine Dimesylate Vanilla Yogurt", 
                "Lisdexamfetamine Dimesylate Orange Juice"
            ], 
            "description": "Single dose of a 70 mg capsule on Day 1", 
            "intervention_name": "Lisdexamfetamine Dimesylate", 
            "intervention_type": "Drug", 
            "other_name": "SPD489"
        }, 
        "intervention_browse": {
            "mesh_term": "Dextroamphetamine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "March 14, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Miami", 
                    "country": "United States", 
                    "state": "Florida"
                }, 
                "name": "Clinical Pharmacology of Miami, Inc"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Phase 1, Open-label, Randomized, 3-period Crossover Study Evaluating the Relative Bioavailability of SPD489 When the Contents Are Emptied Into a Soft Food and Orange Juice in Healthy Adult Subjects", 
        "overall_official": {
            "affiliation": "Clinical Pharmacology of Miami, Inc", 
            "last_name": "Kenneth Lasseter, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body.", 
                "measure": "Area Under the Plasma Concentration-time Curve (AUC) for Lisdexamfetamine Dimesylate", 
                "safety_issue": "No", 
                "time_frame": "Up to 96 hours post-dose"
            }, 
            {
                "description": "Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administrated.", 
                "measure": "Maximum Plasma Concentration (Cmax) for Lisdexamfetamine Dimesylate", 
                "safety_issue": "No", 
                "time_frame": "Up to 96 hours post-dose"
            }, 
            {
                "description": "d-Amphetamine is a metabolite of Lisdexamfetamine Dimesylate and is an active form that is responsible for the drug's therapeutic activity.", 
                "measure": "AUC for D-amphetamine", 
                "safety_issue": "No", 
                "time_frame": "Up to 96 hours post-dose"
            }, 
            {
                "description": "d-Amphetamine is a metabolite of Lisdexamfetamine Dimesylate and is an active form that is responsible for the drug's therapeutic activity.", 
                "measure": "Cmax for D-amphetamine", 
                "safety_issue": "No", 
                "time_frame": "Up to 96 hours-post-dose"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01890785"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Shire", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shire", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}